NanoChip™ Molecular Biology Workstation and the new NC400

Nanogen, integrates advanced microelectronics and molecular biology into a platform technology with potential commercial applications for genetic variations, such as single point mutations, insertion and deletions and SNPs, in the fields of medical diagnostics, biomedical research, genomics, genetic testing and drug discovery. Nanogen's fully automated system, which incorporates a proprietary semiconductor microchip, provides a flexible tool for the rapid identification and analysis of biomolecules. Through the use of microelectronics, the Company's technology enables the active movement and concentration of charged molecules to and from designated microlocations, or test sites, on the semiconductor microchip. The Company believes its semiconductor based platform technology provides a low cost, highly efficient, accurate and versatile integrated system that will shift the paradigm from current manual and mechanical methods to microelectronic systems, thereby significantly improving the quality of healthcare.

The NanoChip™ Molecular Biology Workstation and the new NC400 are integrated bioassay systems, that uniquely bridges the gap between early-stage scientific research and actual clinical practice, and delivers exceptionally accurate, versatile, efficient and user-friendly analytic capability. Nanogen's focus is on translating this genomic data into useful information by providing the tools that simplify genetic research and the use in molecular diagnostics.

Nanogen's objective is to develop commercial applications for its proprietary platform technology and to promote its technology as the standard for molecular identification and analysis. Key elements of the Company's strategy include:- Developing Research and Genomics Applications, developing commercial Applications, establishing strategic collaborations, developing advanced technologies and Point-of-Care applications